South and Central America Anti-Infective Agents Market Forecast to 2028

Report Code : BMIRE00025837 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 12/Sep/2022
South and Central America Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)

The South & Central America anti-infective agents market is projected to grow from US$ 5,713.39 million in 2022 to US$ 6,498.70 million by 2028, at a CAGR of 2.2% during the forecast period.

In South & Central America, the market exhibits growth opportunities with progressive developments in Brazil, such as growing medical tourism and an increasing number of government initiatives to create awareness about anti-infective agents. The growing prevalence of infectious diseases is a major concern among the Brazilian population, thereby increasing the demand for anti-infective agents. These factors stimulate the growth of the anti-infective agent market in this region.

A few major countries contributing to the growth of the anti-infective agents market include Chile, Colombia, Peru, and Bolivia. The aging population, high prevalence of osteoporosis, and growing number of orthopedic surgeries are prime factors for the market growth. The presence of international healthcare technology players further strengthens the market's growth in the region. For instance, Surbiton reaffirms its position as Argentina's flagship Company in the field of medical devices of international quality. Moreover, the company has an active presence in several countries, including Peru, Colombia, and Argentina. Such developments are estimated to contribute to the growth of the Rest of the South & Central America anti-infective agents anti-infective agents market during the forecast period.

Vendors can attract new customers and expand their footprints in emerging markets with new features and technologies. This factor is likely to drive the South & Central America anti-infective agents market at a good CAGR during the forecast period.

South & Central America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Anti-Infective Agents Market Segmentation

The South & Central America anti-infective agents market is segmented based on type, range, route of administration, indication, distribution channel, and country. Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment is expected to account for the largest market share by the end of 2022.

Based on range, the market is segmented into broad spectrum and narrow spectrum. By the end of 2022, the narrow spectrum segment will likely hold a larger market share.

Based on route of administration, the market is segmented into topical, oral, IV, and others. By the end of 2022, the IV segment is likely to hold the largest market share.

Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the others segment is projected to hold the largest share of the market.

Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. By the end of 2022, the hospital pharmacies segment is likely to hold the largest market share.

Based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is expected to hold the largest market share by the end of 2022.

Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG are the leading companies in the South & Central America anti-infective agents market.

The List of Companies - South and Central America Anti-Infective Agents Market

● Abbott

● Allergan Plc.

● Astellas Pharma Inc.

● Bayer AG

● Boehringer Ingelheim International GmbH

● Bristol-Myers Squibb Company

● F. Hoffmann-La Roche Ltd.

● Gilead Sciences, Inc.

● GlaxoSmithKline plc.

● Merck & Co., Inc.

● Novartis AG

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Anti-Infective Agents Market – By Type

1.3.2 SAM Anti-Infective Agents Market – By Range

1.3.3 SAM Anti-Infective Agents Market – By Route of Administration

1.3.4 SAM Anti-Infective Agents Market – By Indication

1.3.5 SAM Anti-Infective Agents Market – By Distribution Channel

1.3.6 SAM Anti-Infective Agents Market – By Country

2. SAM Anti-Infective Agents Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Anti-infective agents Market – Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. SAM Anti-Infectives Agents Market – Key Market Dynamics

5.1 Key Drivers

5.1.1 Chronic Diseases Rising

5.1.2 Rising Government Support for Research Activities and Clinical Trials

5.2 Market Restraints

5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects

5.3 Market Opportunities

5.3.1 Development of Advanced Anti-infective Agents

5.4 Future Trends

5.4.1 R&D Activities in Pharmaceutical Sector Witnessing High Investments

5.5 Impact Analysis

6. Anti-Infectives Agents Market – SAM Analysis

6.1 SAM Anti-Infectives Agents Market Revenue Forecast and Analysis

7. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Type Overview

7.1 SAM Anti-infectives Agents Market, by Type, 2022 & 2028 (%)

7.2 Anti-Viral

7.2.1 Overview

7.2.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)

7.3 Anti-Bacterial

7.3.1 Overview

7.3.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)

7.4 Anti-Fungal

7.4.1 Overview

7.4.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Range

8.1 Overview

8.2 SAM Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)

8.3 Narrow Spectrum

8.3.1 Overview

8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)

8.4 Broad Spectrum

8.4.1 Overview

8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Route of Administration

9.1 Overview

9.2 SAM Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)

9.3 IV

9.3.1 Overview

9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)

9.4 Oral

9.4.1 Overview

9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)

9.5 Topical

9.5.1 Overview

9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Indication

10.1 Overview

10.2 SAM Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)

10.3 HIV

10.3.1 Overview

10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)

10.4 Tuberculosis

10.4.1 Overview

10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)

10.5 Respiratory Infection

10.5.1 Overview

10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)

10.6 Pneumonia

10.6.1 Overview

10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)

10.7 Others

10.7.1 Overview

10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Distribution Channel

11.1 Overview

11.2 SAM Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)

11.3 Hospital Pharmacies

11.3.1 Overview

11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.4 Retail Pharmacies

11.4.1 Overview

11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.5 Specialty Pharmacies

11.5.1 Overview

11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

11.6 E-Commerce

11.6.1 Overview

11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)

11.7 Others

11.7.1 Overview

11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

12. SAM Anti-Infectives Agents Market Analysis and Forecasts To 2028 – Country Analysis

12.1 Overview

12.1.2 SAM Anti-Infective Agents Market Revenue and Forecast to 2028, by Country (%)

12.1.2.1 Brazil: Anti-Infective Agents Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.1 Overview

12.1.2.1.2 Brazil Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.3 Brazil: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)

12.1.2.1.4 Brazil: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)

12.1.2.1.5 Brazil: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.1.6 Brazil: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)

12.1.2.1.7 Brazil: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.2.2 Argentina: Anti-Infective Agents Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.1 Overview

12.1.2.2.2 Argentina Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.3 Argentina: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)

12.1.2.2.4 Argentina: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)

12.1.2.2.5 Argentina: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.2.6 Argentina: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)

12.1.2.2.7 Argentina: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.2.3 Rest of the SAM: Anti-Infective Agents Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.1 Overview

12.1.2.3.2 Rest of the SAM Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.3 Rest of the SAM: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)

12.1.2.3.4 Rest of the SAM: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)

12.1.2.3.5 Rest of the SAM: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.2.3.6 Rest of the SAM: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)

12.1.2.3.7 Rest of the SAM: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)

13. Anti-infectives Agents Market–Industry Landscape

13.1 Overview

13.2 Growth Strategies In The Anti-infective agents Market, 2018-2022

13.3 Organic Developments

13.3.1 Overview

13.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022

13.4 Inorganic Developments

13.4.1 Overview

13.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022

14. Anti-Infectives Agents Market- Company Profiles

14.1 Abbott

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Allergan Plc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Astellas Pharma Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Merck & Co., Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bayer AG

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Bristol-Myers Squibb Company

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Boehringer Ingelheim International GmbH

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 F. HOFFMANN-LA ROCHE LTD.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Gilead Sciences, Inc.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 GlaxoSmithKline plc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Novartis AG

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES.

Table 1.             Brazil Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Brazil Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Argentina Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Argentina Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Argentina Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Argentina Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Rest of the SAM Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of the SAM Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of the SAM Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Rest of the SAM Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Rest of the SAM Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Recent Inorganic Growth Strategies In The Anti-infective agents Market

Table 17.          Glossary of Terms, SAM Anti-infectives Agents Market

The List of Companies - South and Central America Anti-Infective Agents Market

● Abbott

● Allergan Plc.

● Astellas Pharma Inc.

● Bayer AG

● Boehringer Ingelheim International GmbH

● Bristol-Myers Squibb Company

● F. Hoffmann-La Roche Ltd.

● Gilead Sciences, Inc.

● GlaxoSmithKline plc.

● Merck & Co., Inc.

● Novartis AG

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America anti-infective agents market

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the South &; Central America anti-infective agents market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the anti-infective agents market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(South and Central America Anti-Infective Agents Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry